| scholarly article | Q13442814 |
| P50 | author | Shayan Shirazian | Q89229319 |
| P2093 | author name string | Vandana S Mathur | |
| Nobuyuki Miyawaki | |||
| Olufemi Aina | |||
| Linle Hou | |||
| Youngjun Park | |||
| Kathleen Leger | |||
| Nawsheen Chowdhury | |||
| P2860 | cites work | Dialysate calcium concentration of | Q73378777 |
| Short-term efficacy of tacrolimus ointment in severe uremic pruritus | Q73535507 | ||
| Is pruritus in chronic uremic patients related to peripheral somatic and autonomic neuropathy? Study by R-R interval variation test (RRIV) and by sympathetic skin response (SSR) | Q74317479 | ||
| Effects of oral supplementation with evening primrose oil for six weeks on plasma essential fatty acids and uremic skin symptoms in hemodialysis patients | Q77954395 | ||
| Therapeutic effect of topical gamma-linolenic acid on refractory uremic pruritus | Q79782064 | ||
| Uraemic xerosis | Q80490157 | ||
| Gabapentin: a promising drug for the treatment of uremic pruritus | Q80750289 | ||
| Effect of skin care with an emollient containing a high water content on mild uremic pruritus | Q81303696 | ||
| Treatment of uremic pruritus with narrowband ultraviolet B phototherapy: an open pilot study | Q81867634 | ||
| Comparison of cutaneous manifestations in chronic kidney disease with or without dialysis | Q82242960 | ||
| Understanding symptoms in patients with advanced chronic kidney disease managed without dialysis: use of a short patient-completed assessment tool | Q82996977 | ||
| Interleukin-2 serum levels are elevated in patients with uremic pruritus: a novel finding with practical implications | Q83524661 | ||
| Efficacy of topical cromolyn sodium 4% on pruritus in uremic nephrogenic patients: a randomized double-blind study in 60 patients | Q84456276 | ||
| Therapeutic effect of oral nicotinamide on refractory uremic pruritus: a randomized, double-blind study | Q85748869 | ||
| Uremic pruritus: skin divalent ion content and response to ultraviolet phototherapy | Q93564838 | ||
| Gabapentin for uremic pruritus in hemodialysis patients: a qualitative systematic review | Q26750002 | ||
| Assessment of severity and burden of pruritus | Q28066990 | ||
| Cromolyn sodium: a potential therapy for uremic pruritus? | Q30440242 | ||
| The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results | Q33369928 | ||
| Pain measurement. An overview of two commonly used methods | Q33562230 | ||
| Acupuncture for treating uremic pruritus in patients with end-stage renal disease: a systematic review | Q33686591 | ||
| Systematic review of topical capsaicin in the treatment of pruritus | Q33762584 | ||
| The 5-D itch scale: a new measure of pruritus. | Q33871967 | ||
| A longitudinal study of uremic pruritus in hemodialysis patients | Q34075489 | ||
| Development of the kidney disease quality of life (KDQOL) instrument. | Q34317595 | ||
| Sericin cream reduces pruritus in hemodialysis patients: a randomized, double-blind, placebo-controlled experimental study | Q34420464 | ||
| Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end-stage renal disease | Q34542771 | ||
| Randomized, double-blind study with glycerol and paraffin in uremic xerosis. | Q34751820 | ||
| Uremic pruritus, dialysis adequacy, and metabolic profiles in hemodialysis patients: a prospective 5-year cohort study | Q34937539 | ||
| Pharmacokinetics of nalbuphine hydrochloride extended release tablets in hemodialysis patients with exploratory effect on pruritus | Q35358687 | ||
| The Skindex instruments to measure the effects of skin disease on quality of life | Q35714588 | ||
| Uremic pruritus: a review. | Q36271104 | ||
| A Comparison of Uremic Pruritus in Patients Receiving Peritoneal Dialysis and Hemodialysis | Q36664020 | ||
| Comparison of Gabapentin and Ketotifen in Treatment of Uremic Pruritus in Hemodialysis Patients. | Q36697791 | ||
| Comparison of uremic pruritus between patients undergoing hemodialysis and peritoneal dialysis | Q37034706 | ||
| Clinical characteristics and outcomes of end-stage renal disease patients with self-reported pruritus symptoms | Q37413002 | ||
| The role of ondansetron in the management of cholestatic or uremic pruritus--a systematic review | Q38021147 | ||
| Uremic pruritus. | Q38176751 | ||
| Targeting Itch with Ligands Selective for κ Opioid Receptors | Q38415148 | ||
| Nalfurafine hydrochloride to treat pruritus: a review | Q38501089 | ||
| Pruritus in Kidney Disease | Q38583951 | ||
| Pruritus in hemodialysis patients: Results from the Japanese Dialysis Outcomes and Practice Patterns Study (JDOPPS). | Q39207931 | ||
| Randomised crossover trial of naltrexone in uraemic pruritus | Q71849293 | ||
| Disappearance of "uremic" itching after subtotal parathyroidectomy | Q72090729 | ||
| Optimal dialysis improves uremic pruritus | Q72582674 | ||
| Effects of azelastin on pruritus and plasma histamine levels in hemodialysis patients | Q72613687 | ||
| Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial | Q72742589 | ||
| Uremic pruritus: roles of parathyroid hormone and substance P | Q73202115 | ||
| A study on pruritus after parathyroidectomy for secondary hyperparathyroidism | Q73333523 | ||
| Pruritus and skin hydration during dialysis. | Q50992438 | ||
| Itch Severity Scale: a self-report instrument for the measurement of pruritus severity. | Q51907501 | ||
| Uraemic pruritus: relief of itching by gabapentin and pregabalin. | Q52639674 | ||
| A questionnaire for the assessment of pruritus: validation in uremic patients. | Q53476926 | ||
| Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. | Q53566418 | ||
| The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients. | Q53651902 | ||
| Longitudinal predictors of uremic pruritus. | Q54633073 | ||
| Hypervitaminosis A accompanying advanced chronic renal failure | Q55397794 | ||
| [Pruritus in chronic uremic patients in periodic hemodialysis. Treatment with terfenadine (an antagonist of histamine H1 receptors)] | Q61685087 | ||
| Assessment of Pruritus Intensity: Prospective Study on Validity and Reliability of the Visual Analogue Scale, Numerical Rating Scale and Verbal Rating Scale in 471 Patients with Chronic Pruritus | Q62073509 | ||
| Dialysis efficacy and itching in renal failure | Q67583011 | ||
| Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cells | Q67674262 | ||
| Identifying effective treatments for uremic pruritus | Q67907254 | ||
| [Beneficial effect of zinc supplementation on pruritus in hemodialysis patients with special reference to changes in serum histamine levels] | Q68702058 | ||
| Intraepidermal neuron-specific enolase (NSE)-immunoreactive nerve fibres: evidence for sprouting in uremic patients on maintenance hemodialysis | Q69504333 | ||
| Double-blind, placebo-controlled study of nicergoline in the treatment of pruritus in patients receiving maintenance hemodialysis | Q69589382 | ||
| Naloxone in the treatment of uremic pruritus: a case history | Q70584394 | ||
| Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness | Q71695967 | ||
| The effect of ergocalciferol on uremic pruritus severity: a randomized controlled trial | Q39231261 | ||
| Zinc sulfate for relief of pruritus in patients on maintenance hemodialysis | Q39250061 | ||
| Effects of turmeric on uremic pruritus in end stage renal disease patients: a double-blind randomized clinical trial | Q39259414 | ||
| Effect of oral granisetron in uremic pruritus | Q39332055 | ||
| Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). | Q39346154 | ||
| A randomized, placebo-controlled, double-blind trial of ondansetron in renal itch | Q39397866 | ||
| Clinical features of pruritus among patients undergoing maintenance hemodialysis | Q39564303 | ||
| Relief of idiopathic generalized pruritus in dialysis patients treated with activated oral charcoal | Q39570637 | ||
| Ultraviolet phototherapy of uremic pruritus. Long-term results and possible mechanism of action | Q39575108 | ||
| Relief of uremic pruritus with ultraviolet phototherapy | Q39581625 | ||
| Depressive symptoms predict the future risk of severe pruritus in haemodialysis patients: Japan Dialysis Outcomes and Practice Patterns Study | Q39993959 | ||
| Epidemiology and determinants of pruritus in pre-dialysis chronic kidney disease patients | Q40112220 | ||
| Prevalence and Associated Factors of Uraemic Pruritus in Continuous Ambulatory Peritoneal Dialysis Patients | Q41123300 | ||
| Elevated Plasma Histamine in Chronic Uremia Effects of Ketotifen on Pruritus | Q41151097 | ||
| Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial | Q41673941 | ||
| Topical capsaicin therapy in humans with hemodialysis-related pruritus | Q42167689 | ||
| Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. | Q42495512 | ||
| Efficacy of topical hydrating and emollient lotion containing 10% urea ISDIN® plus dexpanthenol (Ureadin Rx 10) in the treatment of skin xerosis and pruritus in hemodialyzed patients: an open prospective pilot trial. | Q42618083 | ||
| Evaluating the association between alterations in mineral metabolism and pruritus in hemodialysis patients | Q43958355 | ||
| Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study | Q44030301 | ||
| Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching after subtotal parathyroidectomy | Q44209697 | ||
| Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies | Q44350825 | ||
| Antipruritic effects of two different 5-HT3 receptor antagonists and an antihistamine in haemodialysis patients | Q44893818 | ||
| A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy | Q44901262 | ||
| A comparative study on the effects of naltrexone and loratadine on uremic pruritus | Q44922690 | ||
| Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial | Q45170301 | ||
| Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study | Q45228027 | ||
| Gabapentin and uremic pruritus in hemodialysis patients | Q46124053 | ||
| A pramoxine-based anti-itch lotion is more effective than a control lotion for the treatment of uremic pruritus in adult hemodialysis patients | Q46343813 | ||
| Uremic pruritus is associated with higher kt/V and serum calcium concentration. | Q46347215 | ||
| Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study | Q46371191 | ||
| Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study | Q46832897 | ||
| Baseline serum levels of mast cell tryptase are raised in hemodialysis patients and associated with severity of pruritus | Q46864210 | ||
| Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment | Q47743575 | ||
| Comparison of pregabalin with ondansetron in treatment of uraemic pruritus in dialysis patients: a prospective, randomized, double-blind study | Q48069006 | ||
| Comparison of the efficacy and safety of zinc sulfate vs. placebo in the treatment of pruritus of hemodialytic patients: a pilot randomized, triple-blind study | Q48106996 | ||
| Narrowband ultraviolet B phototherapy for patients with refractory uraemic pruritus: a randomized controlled trial | Q48298203 | ||
| Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study | Q48381465 | ||
| The impact of pruritus on the quality of life of patients undergoing dialysis: a single centre cohort study. | Q48402804 | ||
| Symptoms in advanced renal disease: a cross-sectional survey of symptom prevalence in stage 5 chronic kidney disease managed without dialysis | Q48447761 | ||
| Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients | Q48502316 | ||
| Acupuncture in haemodialysis patients at the Quchi (LI11) acupoint for refractory uraemic pruritus | Q48546922 | ||
| Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study. | Q48729261 | ||
| Cholestyramine in uraemic pruritus | Q50318025 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 11-26 | |
| P577 | publication date | 2017-01-23 | |
| P1433 | published in | International Journal of Nephrology and Renovascular Disease | Q6051506 |
| P1476 | title | Chronic kidney disease-associated pruritus: impact on quality of life and current management challenges | |
| P478 | volume | 10 |
| Q64238078 | Evaluation of serum levels of neurotrophin 4 and brain-derived nerve growth factor in uremic pruritus patients |
| Q60049131 | Prevalence of chronic kidney disease-associated pruritus, and association with sleep quality among hemodialysis patients in Pakistan |
| Q90403066 | Pruritus Associated With Chronic Kidney Disease: A Comprehensive Literature Review |
| Q94673522 | Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients |
| Q92921841 | Skin Cutibacterium acnes Mediates Fermentation to Suppress the Calcium Phosphate-Induced Itching: A Butyric Acid Derivative with Potential for Uremic Pruritus |
| Q57069531 | Sleep disorders: Serious threats among kidney transplant recipients |
| Q64054140 | Sleep disturbance among Malaysian patients with end-stage renal disease with pruritus |
| Q93143599 | The association between CKD-associated pruritus and quality of life in patients undergoing hemodialysis in Pakistan: A STROBE complaint cross-sectional study |
| Q90358395 | Uremic Pruritus: Prevalence and Impact on Quality of Life and Depressive Symptoms in Hemodialysis Patients |
| Q92422430 | V2-Specific Antibodies in HIV-1 Vaccine Research and Natural Infection: Controllers or Surrogate Markers |
Search more.